Daiichi Sankyo Co 주식 주식분석 | 주식가격 | 뉴스 | 4568.T | JP3475350009 | A0F57T

날짜	Daiichi Sankyo Co 주식 가격
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined
	0 undefined

날짜	Daiichi Sankyo Co 매출	Daiichi Sankyo Co EBIT	Daiichi Sankyo Co 이익
2027e	0 undefined	0 undefined	0 undefined
2026e	0 undefined	0 undefined	0 undefined
2025e	0 undefined	0 undefined	0 undefined
2024	0 undefined	0 undefined	0 undefined
2023	0 undefined	0 undefined	0 undefined
2022	0 undefined	0 undefined	0 undefined
2021	0 undefined	0 undefined	0 undefined
2020	0 undefined	0 undefined	0 undefined
2019	0 undefined	0 undefined	0 undefined
2018	0 undefined	0 undefined	0 undefined
2017	0 undefined	0 undefined	0 undefined
2016	0 undefined	0 undefined	0 undefined
2015	0 undefined	0 undefined	0 undefined
2014	0 undefined	0 undefined	0 undefined
2013	0 undefined	0 undefined	0 undefined
2012	0 undefined	0 undefined	0 undefined
2011	0 undefined	0 undefined	0 undefined
2010	0 undefined	0 undefined	0 undefined
2009	0 undefined	0 undefined	0 undefined
2008	0 undefined	0 undefined	0 undefined
2007	0 undefined	0 undefined	0 undefined
2006	0 undefined	0 undefined	0 undefined

	매출	EBIT	이익
2006	0 JPY	0 JPY	0 JPY
2007	0 JPY	0 JPY	0 JPY
2008	0 JPY	0 JPY	0 JPY
2009	0 JPY	0 JPY	0 JPY
2010	0 JPY	0 JPY	0 JPY
2011	0 JPY	0 JPY	0 JPY
2012	0 JPY	0 JPY	0 JPY
2013	0 JPY	0 JPY	0 JPY
2014	0 JPY	0 JPY	0 JPY
2015	0 JPY	0 JPY	0 JPY
2016	0 JPY	0 JPY	0 JPY
2017	0 JPY	0 JPY	0 JPY
2018	0 JPY	0 JPY	0 JPY
2019	0 JPY	0 JPY	0 JPY
2020	0 JPY	0 JPY	0 JPY
2021	0 JPY	0 JPY	0 JPY
2022	0 JPY	0 JPY	0 JPY
2023	0 JPY	0 JPY	0 JPY
2024	0 JPY	0 JPY	0 JPY
2025e	0 JPY	0 JPY	0 JPY
2026e	0 JPY	0 JPY	0 JPY
2027e	0 JPY	0 JPY	0 JPY

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

514.99	621.51	574.14	312.03	337.54	419.69	320.26	372.3	505.33	374.71	514.34	514.39	594.5	560.52	673.23	671.7	778.75	607.61	876.87
239.57	196.43	166.69	194.49	210.22	203.27	226.35	235.81	243	218.18	228.62	208.67	210.77	360.38	282.54	201.03	214.58	280.68	344.8
0	0	0	0	0	0	0	0	27.19	24.49	21.06	23.69	21.26	59.64	27.24	31.36	52.36	68.56	109.41
121.69	107.76	98.16	139.48	143.22	142.79	169.66	174.43	189.41	150.09	144.27	153.14	172.59	176.07	173.36	200.86	217.91	301.61	438.11
82.22	90.14	87.54	137.51	128.77	128.32	145.26	161.1	25.67	17.87	216.98	297.9	202.43	236.58	227.75	163.47	81.68	236.59	404.84
0.96	1.02	0.93	0.78	0.82	0.89	0.86	0.94	0.99	0.79	1.13	1.2	1.2	1.39	1.38	1.27	1.35	1.5	2.17
289.71	248.86	221.26	250.11	249.54	237.71	261.24	303.43	316.3	266.49	250.17	217.77	217.95	229.09	247.05	265.28	304.07	348.91	421.69
256.34	262.24	216.04	153.73	137.04	102.42	104.56	129.19	138.48	593.23	167.62	141.54	179.98	116.3	97.62	141.01	132.72	131.15	147.97
6.15	1.62	1.3	0.61	0	0	0	0	2.6	2.06	1.78	0.74	0.89	0.8	0.74	0.42	0.18	0.04	0
26.38	41.58	75.67	115.18	107.12	89.61	150.55	149.91	171.42	199.41	210.4	217.04	173.54	169.47	172.5	172.82	163.88	159.61	168.3
9.79	18.57	15.4	77.38	73.77	67.32	82.74	73.54	85.52	71.37	78.69	78.45	75.48	77.85	76.76	77.71	83.56	98.33	108.5
49.27	48.13	31.68	114.08	102.27	89.11	57.86	44.35	149.11	64.39	66.6	61.65	48.38	101.36	126.83	159.52	191.72	275.8	440.66
0.64	0.62	0.56	0.71	0.67	0.59	0.66	0.7	0.86	1.2	0.78	0.72	0.7	0.69	0.72	0.82	0.88	1.01	1.29
1.6	1.64	1.49	1.49	1.49	1.48	1.52	1.64	1.85	1.98	1.9	1.91	1.9	2.09	2.11	2.09	2.22	2.51	3.46

50	50	50	50	50	50	50	50	50	50	50	50	50	50	50	50	50	50	50
179.86	179.86	179.86	105.19	105.19	105.19	105.19	105.19	105.27	105.27	103.93	103.75	94.63	94.63	94.63	94.49	0	0	1.96
0.94	0.97	1.03	0.76	0.75	0.78	0.75	0.77	0.72	0.99	0.99	1.01	1.03	1.15	1.24	1.28	1.17	1.23	1.39
0.74	4.96	-16.26	-51.29	-58.78	-82.44	-100.41	-59.04	121.75	169.04	146.72	124.49	120.51	115.17	82.1	111.48	168.15	200.87	284
80.25	72.36	48.54	19.88	27.46	16.56	22.31	34.21	0	0	0	0	0	0	0	0	0	0	0
1.25	1.28	1.29	0.88	0.87	0.87	0.82	0.9	0.99	1.32	1.3	1.29	1.3	1.41	1.47	1.53	1.39	1.48	1.72
65.6	56.44	46.41	59.42	66.54	58.41	61.82	59.8	66.54	50.05	50.97	54.76	68.81	73.47	70.15	68.69	68.54	80.39	88.74
0	0	0	0	0	0	0	88.99	0	0	0	0	0	0	0	0	0	0	0
157.69	216.51	148.04	184.58	182.05	172.93	262.06	221.25	233.24	226.37	307.94	271.52	263.78	270.66	231.04	255.2	295.64	397.55	621.82
13.55	8.56	0.07	261.11	15.02	25.83	71.08	45.34	67.03	0	0	0	0	0	0	0	0	0	0
0	0	0	3.42	5.2	49.78	0	20.73	94.38	21.08	20.79	0.54	20.52	40.42	49.88	29.68	31.09	52.33	12.84
236.83	281.51	194.51	508.53	268.81	306.95	394.97	436.11	461.19	297.5	379.69	326.82	353.11	384.54	351.07	353.57	395.27	530.26	723.4
3.37	1.53	0.02	63.82	270.92	224.04	204	200.92	265.43	203.56	182.83	281.61	261.59	221.5	216.45	196.5	182.53	140.53	143.16
23.93	36.15	26.72	5.43	29.24	28.46	52.08	45.11	39.84	88.36	33.68	32.29	18.68	17.17	15.64	17.52	12.44	12.65	12.86
82.85	45.5	22.12	28.2	31.03	33.08	34.68	46.19	80.06	85.84	70.8	102.83	131.35	215.14	216.18	245.54	280.29	379.59	893.11
0.11	0.08	0.05	0.1	0.33	0.29	0.29	0.29	0.39	0.38	0.29	0.42	0.41	0.45	0.45	0.46	0.48	0.53	1.05
0.35	0.36	0.24	0.61	0.6	0.59	0.69	0.73	0.85	0.68	0.67	0.74	0.76	0.84	0.8	0.81	0.87	1.06	1.77
1.59	1.64	1.53	1.49	1.47	1.46	1.51	1.63	1.84	1.99	1.96	2.03	2.06	2.25	2.27	2.35	2.26	2.55	3.5

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
136.89	126.91	166.86	-308.26	97.37	120.42	33.92	92.1	99.78	79.94	122.39	87.79	81.02	85.83	141.16	74.12	73.52	126.85
42.55	43.58	42.33	415.57	55.09	55.21	57.38	52.54	51.49	42.02	44.31	47.37	46.68	46.17	52.61	57.38	58.25	67.79
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-45.72	38.8	-90.23	-57.21	-2.05	-26.27	-57.98	-13.24	-118.25	-19.45	2.57	-26.98	-46.07	-45.47	6.95	69.59	0.21	-81.71
-1.29	-101.99	-50.77	28.26	-20.17	-8.22	59.25	-2.15	4.3	40.27	5.01	28.05	26.81	5.51	-4.12	-8.89	7.26	1.58
0.31	0.25	0.13	0.65	3.64	2.89	3.27	4.12	11.18	1.73	1.4	1.51	2.04	1.77	2.53	1.84	1.78	2.08
53	61.95	60.52	58.61	30.41	34.74	31.9	23.56	54.81	21.87	37.44	30.37	22.17	36.15	26.18	24.53	22.58	46.25
132.44	107.3	68.19	78.36	130.23	141.14	92.57	129.25	37.3	142.78	174.28	136.23	108.44	92.03	196.6	192.21	139.23	114.51
-48,586	-42,952	-51,586	-44,602	-31,157	-36,132	-63,700	-78,862	-54,514	-94,630	-69,397	-52,962	-38,008	-66,613	-52,565	-64,093	-76,682	-67,366
-39.26	45.31	-49.44	-413.85	42.63	-62.97	-125.1	-109.28	-161.37	-21.28	-5.97	-96.79	108.57	-142.52	81.67	-39.25	212.34	-257.78
9.33	88.26	2.15	-369.25	73.78	-26.83	-61.4	-30.42	-106.85	73.35	63.43	-43.83	146.58	-75.91	134.24	24.85	289.02	-190.42
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-2.38	1.02	-2.38	197.32	-39.66	16.15	-18.75	-15.09	143.62	120.6	-22.98	80	0	-20	-36.41	-40.39	-34.49	-34.95
-13,691	-162	-33,407	-45,817	-23	-32	-11	-12	-31	-25	-50,239	-50,094	-50,084	-45	-85	-100,190	-15	-24
-50.1	-40.77	-82.9	98.06	-89.12	-25.98	-50.2	-57.33	100.32	-132.2	-122.93	-15.02	-101.77	-66.2	-91.64	-202.43	-86.23	-89.59
-16.71	-1.57	-0.1	-0.15	-0.18	0.15	10.81	0.01	-1.03	0.08	-1.25	-1.04	-5.26	-0.82	-9.79	-12.91	0	0
-17,326	-40,049	-47,016	-53,292	-49,256	-42,246	-42,240	-42,240	-42,238	-42,254	-48,468	-43,889	-46,420	-45,339	-45,356	-48,946	-51,730	-54,616
46.87	112.24	-68.88	-266.56	81.44	43.19	-89.73	-21.75	-8.08	6.3	32.79	23.89	111.65	-114.55	181.03	-43.64	281.93	-220.56
83,850	64,350	16,608	33,759	99,075	105,007	28,869	50,385	-17,210	48,146	104,884	83,272	70,431	25,420	144,036	128,114	62,544	47,148
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Daiichi Sankyo Co 브루토마진	Daiichi Sankyo Co 이익 마진	Daiichi Sankyo Co EBIT-마진	Daiichi Sankyo Co 이익 마진
2027e	0 %	0 %	0 %
2026e	0 %	0 %	0 %
2025e	0 %	0 %	0 %
2024	0 %	0 %	0 %
2023	0 %	0 %	0 %
2022	0 %	0 %	0 %
2021	0 %	0 %	0 %
2020	0 %	0 %	0 %
2019	0 %	0 %	0 %
2018	0 %	0 %	0 %
2017	0 %	0 %	0 %
2016	0 %	0 %	0 %
2015	0 %	0 %	0 %
2014	0 %	0 %	0 %
2013	0 %	0 %	0 %
2012	0 %	0 %	0 %
2011	0 %	0 %	0 %
2010	0 %	0 %	0 %
2009	0 %	0 %	0 %
2008	0 %	0 %	0 %
2007	0 %	0 %	0 %
2006	0 %	0 %	0 %

	브루토마진	EBIT-마진	이익 마진
2006	0 %	0 %	0 %
2007	0 %	0 %	0 %
2008	0 %	0 %	0 %
2009	0 %	0 %	0 %
2010	0 %	0 %	0 %
2011	0 %	0 %	0 %
2012	0 %	0 %	0 %
2013	0 %	0 %	0 %
2014	0 %	0 %	0 %
2015	0 %	0 %	0 %
2016	0 %	0 %	0 %
2017	0 %	0 %	0 %
2018	0 %	0 %	0 %
2019	0 %	0 %	0 %
2020	0 %	0 %	0 %
2021	0 %	0 %	0 %
2022	0 %	0 %	0 %
2023	0 %	0 %	0 %
2024	0 %	0 %	0 %
2025e	0 %	0 %	0 %
2026e	0 %	0 %	0 %
2027e	0 %	0 %	0 %

날짜	Daiichi Sankyo Co 주당 매출	Daiichi Sankyo Co EBIT 당 주식	Daiichi Sankyo Co 주당 이익
2027e	0 undefined	0 undefined	0 undefined
2026e	0 undefined	0 undefined	0 undefined
2025e	0 undefined	0 undefined	0 undefined
2024	0 undefined	0 undefined	0 undefined
2023	0 undefined	0 undefined	0 undefined
2022	0 undefined	0 undefined	0 undefined
2021	0 undefined	0 undefined	0 undefined
2020	0 undefined	0 undefined	0 undefined
2019	0 undefined	0 undefined	0 undefined
2018	0 undefined	0 undefined	0 undefined
2017	0 undefined	0 undefined	0 undefined
2016	0 undefined	0 undefined	0 undefined
2015	0 undefined	0 undefined	0 undefined
2014	0 undefined	0 undefined	0 undefined
2013	0 undefined	0 undefined	0 undefined
2012	0 undefined	0 undefined	0 undefined
2011	0 undefined	0 undefined	0 undefined
2010	0 undefined	0 undefined	0 undefined
2009	0 undefined	0 undefined	0 undefined
2008	0 undefined	0 undefined	0 undefined
2007	0 undefined	0 undefined	0 undefined
2006	0 undefined	0 undefined	0 undefined

	주당 매출	EBIT 당 주식	주당 이익
2006	0 JPY	0 JPY	0 JPY
2007	0 JPY	0 JPY	0 JPY
2008	0 JPY	0 JPY	0 JPY
2009	0 JPY	0 JPY	0 JPY
2010	0 JPY	0 JPY	0 JPY
2011	0 JPY	0 JPY	0 JPY
2012	0 JPY	0 JPY	0 JPY
2013	0 JPY	0 JPY	0 JPY
2014	0 JPY	0 JPY	0 JPY
2015	0 JPY	0 JPY	0 JPY
2016	0 JPY	0 JPY	0 JPY
2017	0 JPY	0 JPY	0 JPY
2018	0 JPY	0 JPY	0 JPY
2019	0 JPY	0 JPY	0 JPY
2020	0 JPY	0 JPY	0 JPY
2021	0 JPY	0 JPY	0 JPY
2022	0 JPY	0 JPY	0 JPY
2023	0 JPY	0 JPY	0 JPY
2024	0 JPY	0 JPY	0 JPY
2025e	0 JPY	0 JPY	0 JPY
2026e	0 JPY	0 JPY	0 JPY
2027e	0 JPY	0 JPY	0 JPY

	주식 수량
2006	731 백만 Aktien
2007	729 백만 Aktien
2008	722 백만 Aktien
2009	708 백만 Aktien
2010	704 백만 Aktien
2011	705 백만 Aktien
2012	705 백만 Aktien
2013	705 백만 Aktien
2014	705 백만 Aktien
2015	705.44 백만 Aktien
2016	2.07 조. Aktien
2017	2.02 조. Aktien
2018	1.99 조. Aktien
2019	1.95 조. Aktien
2020	1.95 조. Aktien
2021	1.94 조. Aktien
2022	1.92 조. Aktien
2023	1.92 조. Aktien
2024	1.92 조. Aktien
2025e	1.92 조. Aktien
2026e	1.92 조. Aktien
2027e	1.92 조. Aktien

날짜	EPS-예상치	EPS-실제	보고 분기
	0	0 (89.52 %)	2025 Q1
	0	0 (153.7 %)	2024 Q4
	0	0 (102.44 %)	2024 Q3
	0	0 (1.93 %)	2024 Q2
	0	0 (72.63 %)	2024 Q1
	0	0 (1,195.27 %)	2023 Q4
	0	0 (-26.05 %)	2023 Q3
	0	0 (45.88 %)	2023 Q2
	0	0 (-23.04 %)	2023 Q1
	0	0 (-79.07 %)	2022 Q4
	0	0 (88.49 %)	2022 Q3
	0	0 (30.87 %)	2022 Q2
	0	0 (54.66 %)	2022 Q1
	0	0 (101.49 %)	2021 Q4
	0	0 (9.31 %)	2021 Q3
	0	0 (42.68 %)	2021 Q2
	0	0 (18.42 %)	2021 Q1
	0	0 (77.61 %)	2020 Q4
	0	0 (120.98 %)	2020 Q3
	0	0 (-13.49 %)	2020 Q2
	0	0 (112.6 %)	2020 Q1
	0	0 (221.8 %)	2019 Q4
	0	0 (41.38 %)	2019 Q3
	0	0 (19.93 %)	2019 Q2
	0	0 (31.31 %)	2019 Q1
	0	0 (-77.71 %)	2018 Q4
	0	0 (69.94 %)	2018 Q3
	0	0 (-33.57 %)	2018 Q2
	0	0 (6.63 %)	2018 Q1
	0	0 (-195.96 %)	2017 Q4
	0	0 (82.63 %)	2017 Q3
	0	0 (-13.79 %)	2017 Q2
	0	0 (40.05 %)	2017 Q1
	0	0 (-4.96 %)	2016 Q4
	0	0 (110.13 %)	2016 Q3
	0	0 (70.99 %)	2016 Q2
	0	0 (58.4 %)	2016 Q1
	0	0 (601.93 %)	2015 Q3
	0	0 (261.63 %)	2015 Q2
	0	0 (0.39 %)	2015 Q1
	0	0 (110.82 %)	2014 Q3
	0	0 (18.6 %)	2014 Q2
	0	0 (-33.21 %)	2014 Q1
	0	0 (293.59 %)	2013 Q3
	0	0 (796.02 %)	2013 Q2
	0	0 (-14.92 %)	2013 Q1
	0	0 (-616.7 %)	2012 Q4
	0	0 (-176.2 %)	2012 Q3
	0	0 (20.07 %)	2012 Q2
	0	0 (46.24 %)	2012 Q1
	0	0 (-2,413.44 %)	2011 Q4
	0	0 (66.07 %)	2011 Q3
	0	0 (176.71 %)	2011 Q2
	0	0 (119.41 %)	2011 Q1
	0	0 (-67.82 %)	2010 Q4
	0	0 (31.89 %)	2010 Q2
	0	0 (-184.67 %)	2010 Q1
	0	0 (-998.3 %)	2009 Q3
	0	0 (-14.5 %)	2009 Q2
	0	0 (35.43 %)	2009 Q1

%-지분	이름	주식	변경
6.08969 %	Capital Research Global Investors	116,260,265	-3,663,900
4.49749 %	Nippon Life Insurance Company	85,863,000	0
4.39877 %	Nomura Asset Management Co., Ltd.	83,978,388	7,800
3.33030 %	Mitsubishi UFJ Trust and Banking Corporation	63,579,810	-5,078,665
3.18315 %	Wellington Management Company, LLP	60,770,673	-107,712
2.91356 %	Asset Management One Co., Ltd.	55,623,700	-6,769,000
2.82703 %	The Vanguard Group, Inc.	53,971,729	176,400
2.37924 %	BlackRock Institutional Trust Company, N.A.	45,422,794	520,300
2.07151 %	Nikko Asset Management Co., Ltd.	39,547,862	104,400
2.02626 %	Daiwa Asset Management Co., Ltd.	38,684,082	-99,825
1.32647 %	Norges Bank Investment Management (NBIM)	25,324,000	-6,267,252
1.31023 %	Mizuho Bank, Ltd.	25,014,130	-13,367,800
1.24992 %	Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	23,862,600	638,900
0.84358 %	Nuveen LLC	16,105,054	-11,800
0.78496 %	Mizuho Trust & Banking Co., Ltd.	14,985,870	0
0.65796 %	Geode Capital Management, L.L.C.	12,561,292	99,800
0.64638 %	T. Rowe Price Associates, Inc.	12,340,201	-1,963,000
0.56927 %	BlackRock Advisors (UK) Limited	10,868,048	-87,600
0.55944 %	Invesco Advisers, Inc.	10,680,476	6,900
0.46910 %	BlackRock Investment Management (UK) Ltd.	8,955,717	-107,500
0.36961 %	JP Morgan Asset Management	7,056,402	134,900
0.26609 %	Medipal Holdings Corp	5,080,089	0
0.24809 %	Charles Schwab Investment Management, Inc.	4,736,349	38,705
0.23674 %	Mizuho Securities Co., Ltd.	4,519,674	453,882
0.21976 %	Amundi Asset Management, SAS	4,195,429	-1,047,777
0.20570 %	CPP Investment Board	3,927,000	-11,000
0.20150 %	Carmignac Gestion	3,846,926	3,846,926
0.18439 %	BlackRock Investment Management, LLC	3,520,300	-1,400
0.18334 %	Aviva Investors Global Services Limited	3,500,215	-23,692
0.18201 %	DWS Investments UK Limited	3,474,745	76,163
0.16316 %	OrbiMed Advisors, LLC	3,114,850	0
0.15712 %	Toray Industries Inc	2,999,583	0
0.15579 %	State Street Global Advisors (US)	2,974,215	0
0.15193 %	Artisan Partners Limited Partnership	2,900,500	-1,805,200
0.15047 %	DWS Investment GmbH	2,872,721	-44,067
0.14912 %	T. Rowe Price Japan, Inc.	2,846,905	161,800
0.14507 %	ClearBridge Investments, LLC	2,769,581	-119,012
0.14239 %	JPMorgan Asset Management U.K. Limited	2,718,400	20,500
0.13806 %	HSBC Global Asset Management (UK) Limited	2,635,817	70,138
0.13450 %	Fidelity Management & Research Company LLC	2,567,784	53,617
0.13317 %	California State Teachers Retirement System	2,542,409	192,000
0.12599 %	Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.	2,405,362	-5,610,276
0.12237 %	JPMorgan Asset Management (Asia Pacific) Limited	2,336,137	0
0.12146 %	UBS Asset Management (UK) Ltd.	2,318,875	-2,200
0.12078 %	APG Asset Management N.V.	2,305,898	653,597
0.11830 %	Caixabank Asset Management SGIIC, S.A.U.	2,258,575	0
0.11334 %	Legal & General Investment Management Ltd.	2,163,867	9,400
0.11281 %	RBC Global Asset Management (Asia) Limited	2,153,631	0
0.11241 %	Handelsbanken Kapitalförvaltning AB	2,146,100	-45,841
0.10582 %	Credit Suisse Funds AG	2,020,188	23,600
0.10222 %	FMR Investment Management (U.K.) Limited	1,951,485	56,000
0.09902 %	Goldman Sachs Asset Management International	1,890,466	0
0.09535 %	Sumitomo Mitsui Trust Bank, Limited	1,820,325	6,205
0.09531 %	William Blair Investment Management, LLC	1,819,600	-8,300
0.09083 %	Kissei Pharmaceutical Co Ltd	1,734,000	0
0.08836 %	Royal London Asset Management Ltd.	1,686,900	25,900
0.08224 %	Standard Life Assurance Limited	1,570,041	-33,629
0.07730 %	Nissay Asset Management Corp.	1,475,846	2,948
0.07470 %	Swedbank Robur Fonder AB	1,426,200	-14,900
0.07358 %	Norinchukin Zenkyoren Asset Management Co., Ltd.	1,404,658	-24,300
0.07292 %	BNP Paribas Asset Management USA, Inc.	1,392,200	0
0.07281 %	Franklin Equity Group	1,390,000	-30,000
0.07080 %	UBS Asset Management (Switzerland)	1,351,654	-12,500
0.06961 %	Northern Trust Global Investments Limited	1,329,000	29,500
0.06718 %	Janus Henderson Investors	1,282,600	300
0.06587 %	Capital International, Inc.	1,257,568	310,600
0.06415 %	WCM Investment Management	1,224,658	46,702
0.06050 %	Rheos Capital Works Inc.	1,155,101	1,155,101
0.05909 %	Mellon Investments Corporation	1,128,111	27,700
0.05905 %	Candriam Luxembourg S.A.	1,127,300	-228,600
0.05883 %	BlackRock Asset Management Canada Limited	1,123,200	23,200
0.05795 %	Vanguard Investments Australia Ltd.	1,106,304	-733
0.05683 %	Toho Holdings Co Ltd	1,084,896	0
0.05243 %	Sumitomo Mitsui DS Asset Management Company, Limited	1,001,037	139,017
0.05238 %	MUFG Bank, Ltd.	1,000,000	1,000,000
0.05050 %	Storebrand Kapitalforvaltning AS	964,202	-1,400
0.04907 %	Baillie Gifford & Co.	936,900	206,900
0.04792 %	BNP Paribas Asset Management UK Limited	914,900	63,000
0.04740 %	Franklin Templeton Portfolio Advisors, Inc	905,014	29,014
0.04728 %	SEB Investment Management AB	902,723	-6,721
0.04715 %	State Street Global Advisors (UK) Ltd.	900,063	-1,398
0.04714 %	Hitachi Ltd	900,000	0
0.04592 %	Zürcher Kantonalbank (Asset Management)	876,604	0
0.04493 %	Dimensional Fund Advisors, L.P.	857,838	14,700
0.04400 %	Franklin Templeton Institutional, LLC	840,000	-100,000
0.04320 %	BMO Asset Management Inc.	824,712	52,000
0.04245 %	PGGM Vermogensbeheer B.V.	810,475	8,181
0.04184 %	Deka Investment GmbH	798,704	74
0.03995 %	DBX Advisors LLC.	762,702	52,300
0.03977 %	Vanguard Global Advisers LLC	759,178	54,700
0.03938 %	Nomura Asset Management (UK) Ltd.	751,803	165,500
0.03624 %	Amundi Japan Ltd.	691,777	8,900
0.03496 %	Bellevue Asset Management AG	667,500	5,000
0.03456 %	State Street Global Advisors Ireland Limited	659,710	8,300
0.03298 %	Capital International K.K.	629,708	-8,132,392
0.03292 %	BlackRock Financial Management, Inc.	628,500	8,200
0.03253 %	Tredje AP Fonden	621,000	-52,700
0.03219 %	Capfi Delen Asset Management	614,600	0
0.03185 %	Manulife Investment Management (North America) Limited	608,010	-8,368
0.03143 %	MFS Institutional Advisors, Inc	600,000	106,600

What values and corporate philosophy does Daiichi Sankyo Co represent?

Daiichi Sankyo Co Ltd represents values of innovation, integrity, and patient-centricity in line with its corporate philosophy. The company focuses on discovering, developing, and delivering innovative pharmaceutical solutions to improve the quality of life for patients worldwide. Daiichi Sankyo is committed to the highest ethical standards, ensuring transparency and trust in its business practices. With a strong emphasis on research and development, the company aims to pioneer new treatment options and contribute to the advancement of healthcare globally. Daiichi Sankyo Co Ltd's dedication to improving patient outcomes and its commitment to scientific excellence make it a leading player in the pharmaceutical industry.

In which countries and regions is Daiichi Sankyo Co primarily present?

Daiichi Sankyo Co Ltd is primarily present in Japan, as it is a Japanese pharmaceutical company headquartered in Tokyo.

What significant milestones has the company Daiichi Sankyo Co achieved?

Daiichi Sankyo Co Ltd has achieved several significant milestones. In 2006, the company acquired the German biotech firm U3 Pharma, expanding its presence in the global pharmaceutical market. In 2008, Daiichi Sankyo formed a collaborative partnership with the global pharmaceutical company Eli Lilly, focusing on the development of diabetes treatments. In 2011, the company received approval from the U.S. Food and Drug Administration (FDA) for its anti-hypertensive drug, Benicar. Additionally, Daiichi Sankyo has made advancements in oncology research and has received approvals for multiple cancer therapies around the world. These milestones demonstrate Daiichi Sankyo's commitment to innovation and its strong position in the pharmaceutical industry.

What is the history and background of the company Daiichi Sankyo Co?

Daiichi Sankyo Co Ltd is a prominent global pharmaceutical company. Founded in 2005 through the merger of Daiichi Pharmaceutical Co Ltd and Sankyo Co Ltd, the company has a rich history and extensive background in the healthcare industry. Daiichi Sankyo is dedicated to improving patient lives by developing innovative medicines to address unmet medical needs. With a focus on research and development, they strive to bring new treatments to market in therapeutic areas such as cardiovascular disease, cancer, and diabetes. Daiichi Sankyo's commitment to delivering high-quality pharmaceuticals has earned them a strong reputation globally.

Who are the main competitors of Daiichi Sankyo Co in the market?

The main competitors of Daiichi Sankyo Co Ltd in the market include major pharmaceutical companies such as Novartis AG, Pfizer Inc., and Takeda Pharmaceutical Company Limited. These companies operate in the same industry and provide similar products and services, competing for market share and customers worldwide.

In which industries is Daiichi Sankyo Co primarily active?

Daiichi Sankyo Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Daiichi Sankyo Co?

The business model of Daiichi Sankyo Co Ltd revolves around the research, development, manufacturing, and marketing of pharmaceutical products. As a global pharmaceutical company, Daiichi Sankyo focuses on innovative solutions in the areas of cardiovascular, oncology, and immunology. With a commitment to improving human health and well-being, Daiichi Sankyo strives to deliver high-quality medications that address unmet medical needs. Through strategic collaborations and acquisitions, the company aims to expand its product portfolio and reach a wider patient population. Daiichi Sankyo's business model centers on providing effective and safe healthcare solutions while contributing to scientific advancements in the field of pharmaceuticals.

Daiichi Sankyo Co 2024의 P/E 비율은 얼마입니까?

Daiichi Sankyo Co에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Daiichi Sankyo Co 2024의 KUV는 얼마입니까?

Daiichi Sankyo Co에 대한 현재 KUV는 계산할 수 없습니다.

Daiichi Sankyo Co의 AlleAktien 품질 점수는 얼마인가요?

Daiichi Sankyo Co에 대한 AlleAktien 품질 점수는 6/10입니다.

Daiichi Sankyo Co 2024의 매출은 얼마인가요?

Daiichi Sankyo Co에 대한 현재 매출은 계산할 수 없습니다.

Daiichi Sankyo Co 2024의 이익은 얼마인가요?

Daiichi Sankyo Co의 현재 이익을 계산할 수 없습니다.

Daiichi Sankyo Co은 무엇을 하나요?

Daiichi Sankyo Co Ltd is a globally leading company in the pharmaceutical industry, focusing on the research and development of new innovative drugs. The company was formed in 2005 through the merger of two Japanese companies, Daiichi Pharmaceutical Co Ltd and Sankyo Co Ltd, and is headquartered in Tokyo, Japan. Daiichi Sankyo's business model consists of three main divisions: Pharma, Generics, and Consumer Healthcare. In the Pharma division, the company develops and distributes innovative drugs in the areas of oncology, cardiovascular diseases, pain management, and infectious diseases. Daiichi Sankyo utilizes a combination of preclinical research, clinical trials, and partnerships with other companies in the industry. An important component of Daiichi Sankyo's business model is the Generics division, where the company develops and distributes lower-cost versions of existing drugs. With this strategy, the company aims to expand its reach and generate higher revenue without bearing the high costs of researching and developing new medications. Daiichi Sankyo's Consumer Healthcare division includes products such as dietary supplements, vitamins, and medical foods. With this segment of the business, the company also aims to enter this market segment and expand its reach to a wider range of products. In the field of oncology, Daiichi Sankyo has developed and marketed some important drugs, including the cancer drugs Lonsurf and Enhertu. The company has also formed partnerships with other companies in the field of cancer research to create synergies and develop the best treatment options. In the cardiovascular diseases division, Daiichi Sankyo develops products such as the blood pressure medication Olmesartan and the antiplatelet drug Prasugrel. The company has also been involved in the development and marketing of the pain medication Celecoxib, used in the treatment of arthritis and other pain conditions. In pain management, Daiichi Sankyo develops the pain medication Tapentadol, used in the treatment of severe and chronic pain. The company has also formed partnerships with other companies in the field of pain management to expand its product range and provide better treatment options for patients. Overall, Daiichi Sankyo pursues a broad business model that includes the development of innovative products in various segments of the pharmaceutical industry, as well as the marketing of lower-cost versions of existing medications and the marketing of products in the Consumer Healthcare sector. With a strong focus on research and development, partnerships, and collaboration with other companies in the industry, the company is well positioned to continue expanding in the pharmaceutical industry and develop innovative solutions for patient healthcare.

Daiichi Sankyo Co 배당금은 얼마입니까?

Daiichi Sankyo Co은(는) 연간 번의 배당을 통해 0 JPY의 배당금을 지급합니다.

Daiichi Sankyo Co이 얼마나 자주 배당을 지급하나요?

Daiichi Sankyo Co의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Daiichi Sankyo Co ISIN이 무엇입니까?

Daiichi Sankyo Co의 ISIN은 JP3475350009입니다.

Daiichi Sankyo Co WKN은 무엇인가요?

Daiichi Sankyo Co의 WKN은 A0F57T입니다.

Daiichi Sankyo Co 티커는 무엇인가요?

Daiichi Sankyo Co의 티커는 4568.T입니다.

Daiichi Sankyo Co이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Daiichi Sankyo Co은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Daiichi Sankyo Co은(는) 60.84 JPY의 배당금을 지급할 것으로 예상됩니다.

Daiichi Sankyo Co의 배당 수익률은 얼마입니까?

Daiichi Sankyo Co의 현재 배당 수익률은 입니다.

Daiichi Sankyo Co의 배당금은 언제 지급되나요?

Daiichi Sankyo Co은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Daiichi Sankyo Co의 배당금은 얼마나 안전한가요?

Daiichi Sankyo Co은(는) 지난 22년 동안 매년 배당금을 지급했습니다.

Daiichi Sankyo Co의 배당금은 얼마입니까?

향후 12개월 동안 60.84 JPY의 배당금이 예상됩니다. 이는 배당수익률 1.29 %에 해당합니다.

Daiichi Sankyo Co이(가) 속해 있는 섹터는 어디인가요?

Daiichi Sankyo Co은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Daiichi Sankyo Co kaufen, um die vorherige Dividende zu erhalten?

Daiichi Sankyo Co의 마지막 배당금을 30 JPY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Daiichi Sankyo Co의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Daiichi Sankyo Co의 2023년도 배당금은 얼마였습니까?

2023년에 Daiichi Sankyo Co는 35 JPY를 배당금으로 지급했습니다.

Daiichi Sankyo Co는 어떤 화폐로 배당금을 지급하나요?

Daiichi Sankyo Co의 배당금은 JPY에 지급됩니다.

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e
0.93	0.93	0.88	0.84	0.95	0.97	0.94	1	1.12	0.92	0.99	0.96	0.96	0.93	0.98	0.96	1.04	1.28	1.6	1.88	2.13	2.51
-	0.39	-5.31	-4.31	13.06	1.60	-2.97	6.30	12.06	-17.78	7.30	-3.18	0.53	-3.17	5.60	-1.96	8.56	22.36	25.28	17.22	13.68	17.51
68.60	71.47	73.35	74.54	70.80	70.88	71.38	68.57	64.02	64.86	67.70	63.42	63.96	60.78	65.04	64.85	66.19	71.57	74.07	-	-	-
0.64	0.66	0.65	0.63	0.67	0.69	0.67	0.68	0.72	0.6	0.67	0.61	0.61	0.57	0.64	0.62	0.69	0.91	1.19	0	0	0
0.15	0.14	0.16	-0.27	0.1	0.12	0.1	0.1	0.11	0.07	0.13	0.09	0.08	0.08	0.14	0.06	0.07	0.12	0.21	25.69	28.22	0
16.71	14.67	17.73	-31.91	10.00	12.41	10.46	10.07	9.98	8.09	13.22	9.31	7.94	9.00	14.14	6.63	6.99	9.43	13.21	1,368.25	1,322.28	-
87.34	78.55	97.66	-215.5	41.85	70.12	10.38	66.62	60.94	322.12	82.28	53.47	60.28	93.41	129.07	75.96	66.97	109.19	200.73	226.74	285.75	394.8
-	-10.07	24.33	-320.66	-119.42	67.55	-85.19	541.64	-8.52	428.56	-74.46	-35.02	12.75	54.95	38.18	-41.15	-11.83	63.04	83.84	12.96	26.03	38.16
0.73	0.73	0.72	0.71	0.7	0.71	0.71	0.71	0.71	0.71	2.07	2.02	1.99	1.95	1.95	1.94	1.92	1.92	1.92	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Scope 1 - 직접 방출	86,006
스코프 2 - 구매한 에너지로부터의 간접적인 배출	23,729
Scope 3 - 가치 창출 체인 내의 간접 배출	2,205,979
총 CO₂ 배출량	109,735
CO₂ 감소 전략	✅
석탄 에너지	❌
원자력	❌
동물 실험	✅
펠츠 & 레더	—
살충제	—
팜 오일	—
담배	❌
유전자 변형 생물체	❌
기후 개념	—
지속 가능한 임업	—
재활용 규정	✅
환경 친화적인 포장	✅
위험물질	✅
연료 소비량과 효율성	✅
물 사용량 및 효율성	✅

여성 직원 비율	39.8
관리 직위에서의 여성 비율	—
아시아 직원 비율	—
아시아 경영진 비율	—
히스패닉/라티노 직원 비율	—
히스패닉/라티노 관리 부문 지분	—
흑인 직원 비율	—
블랙 매니지먼트 지분	—
흰색 종업원의 비율	—
화이트 매니지먼트 지분	—
성인 콘텐츠	❌
알코올	❌
무기	—
총기	❌
도박	❌
군사 계약	❌
인권 개념	✅
개인정보 보호 정책	—
작업 및 건강 보호	✅
카톨릭	✅

환경 보고	✅
이해관계자 참여	✅
콜백 정책	✅
카르텔법	❌

증권거래소	Daiichi Sankyo Co 티커
뒤셀도르프	D4S.DU
프랑크푸르트	D4S.F
JPX	4568.T
뮌헨	D4S.MU
PNK	DSKYF

Daiichi Sankyo Co 티커	Daiichi Sankyo Co FIGI
4568:JP	BBG000BWPLT1
4568:JT	BBG000BWPMB8
4568:JJ	BBG000BWPS89
4568:JE	BBG000BWPT41
4568:JI	BBG000BWPTF9
D4S:GR	BBG000DXRM40
D4S:GF	BBG000DXRMJ4
D4S:GD	BBG000DXRMZ6
D4S:GS	BBG000DXRNN7
D4S:GM	BBG000DXRNW7
D4S:GB	BBG000DXRP70
D4S:GI	BBG000DXRQL2
DSKYF:US	BBG000JG7CY2
DSKYF:PQ	BBG000JG7QS8
DSKYF:UV	BBG000JG7T11
4568:JU	BBG002QKCFJ5
4568JPY:EO	BBG005QKW358
4568JPY:XH	BBG005QKW385
4568JPY:XF	BBG005QKW3B1
4568JPY:XE	BBG005QKW3D9
4568JPY:XJ	BBG005QKW3F7
4568JPY:XL	BBG005QKW3H5
4568JPY:XG	BBG005QKW3J3
4568JPY:XO	BBG005QKW3K1
4568JPY:XS	BBG005QKW3Q5
4568JPY:XA	BBG005QKW3R4
4568JPY:E1	BBG005QKW3S3
4568JPY:XT	BBG005QKW3T2
4568JPY:XW	BBG005QKW3V9
4568JPY:XU	BBG005QKW3W8
4568JPY:XV	BBG005QKW3Y6
4568JPY:EU	BBG005QKW4W6
4568:JW	BBG00875HD42
D4S:QT	BBG00D0NBX05
4568EUR:EO	BBG00D0NQWZ3
4568EUR:XH	BBG00D0NQX54
4568EUR:XF	BBG00D0NQX90
4568EUR:XE	BBG00D0NQXD5
4568EUR:XJ	BBG00D0NQXF3
4568EUR:XL	BBG00D0NQXG2
4568EUR:XG	BBG00D0NQXH1
4568EUR:XO	BBG00D0NQXJ9
4568EUR:XS	BBG00D0NQXN4
4568EUR:XA	BBG00D0NQXP2
4568EUR:E1	BBG00D0NQXQ1
4568EUR:XT	BBG00D0NQXR0
4568EUR:XW	BBG00D0NQXS9
4568EUR:XU	BBG00D0NQXT8
4568EUR:XV	BBG00D0NQXV5
4568EUR:EU	BBG00D0NQXX3
D4S:GZ	BBG00FGWY4Q4
4568JPY:XX	BBG00JN850Y2
4568EUR:XX	BBG00JN8HR89
4568USD:X2	BBG00K62KFT7
4568USD:XB	BBG00K62KFV4
4568USD:XH	BBG00K62KFX2
4568USD:XF	BBG00K62KFZ0
4568USD:XE	BBG00K62KG15
4568USD:XJ	BBG00K62KG24
4568USD:XL	BBG00K62KG33
4568USD:XG	BBG00K62KG42
4568USD:XO	BBG00K62KG51
4568USD:XS	BBG00K62KG97
4568USD:XA	BBG00K62KGB4
4568USD:E1	BBG00K62KGC3
4568USD:XT	BBG00K62KGD2
4568USD:XW	BBG00K62KGF0
4568USD:XU	BBG00K62KGG9
4568USD:XV	BBG00K62KGH8
4568USD:XM	BBG00K62KGJ6
4568USD:XQ	BBG00K62KGL3
4568USD:XX	BBG00K62KGM2
4568USD:XZ	BBG00K62KGN1
4568USD:EU	BBG00K62KGQ8
D4S:TH	BBG00PYS9PX4
4568JPY:X2	BBG00Q6RTVL3
4568JPY:EP	BBG00QNTRT19
4568JPY:EZ	BBG00QNTRT37
D4S:LA	BBG018H8BJ65
D4S:LU	BBG018J1ZLS3
4568:JV	BBG0193R9M53
D4S:BU	BBG01BPDCRM1
4568N:MM	BBG01C70D358
4568N:MF	BBG01C70D367
4568N:MU	BBG01C70D376

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

가격

가격

티커4568.T

ISINJP3475350009

WKNA0F57T

Daiichi Sankyo Co 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Daiichi Sankyo Co 주가 이력

Daiichi Sankyo Co 주식 매출, EBIT, 이익 JP3475350009 · A0F57T

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Daiichi Sankyo Co 매출, 이익 및 EBIT 역사

Daiichi Sankyo Co 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Daiichi Sankyo Co 주식 마진 JP3475350009 · A0F57T

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Daiichi Sankyo Co 마진 역사

Daiichi Sankyo Co 주식 매출, EBIT, 주당 순이익 JP3475350009 · A0F57T

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Daiichi Sankyo Co 매출, 이익 및 EBIT 주당 역사

Daiichi Sankyo Co 주식 및 주식 분석

Daiichi Sankyo Co Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Daiichi Sankyo Co 역사적인 P/E, EBIT 및 P/S에 따른 평가

Daiichi Sankyo Co 주식 수량 JP3475350009 · A0F57T

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Daiichi Sankyo Co 주식 분할

Daiichi Sankyo Co 수익 예상

Daiichi Sankyo Co 수익 놀라움

Eulerpool ESG Scorecard© Daiichi Sankyo Co 주식을 위해

Eulerpool World ESG Rating (EESG©)

93/ 100

🌱 Environment

👫 Social

🏛️ Governance

환경

소셜 (사회적)

지배구조 (기업 경영)

Daiichi Sankyo Co 주식 주주 구조

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

티커
4568.T

ISIN
JP3475350009

WKN
A0F57T